Viewing Study NCT00313495



Ignite Creation Date: 2024-05-05 @ 4:49 PM
Last Modification Date: 2024-10-26 @ 9:24 AM
Study NCT ID: NCT00313495
Status: UNKNOWN
Last Update Posted: 2011-03-07
First Post: 2006-04-10

Brief Title: Cooperative Huntingtons Observational Research Trial
Sponsor: HP Therapeutics Foundation
Organization: HP Therapeutics Foundation

Study Overview

Official Title: Cooperative Huntingtons Observational Research Trial
Status: UNKNOWN
Status Verified Date: 2011-03
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to collect prospective data from individuals who are part of a Huntington Disease HD family in order to relate phenotypes between individuals and families with each other and genetic factors in order to learn more about HD develop potential treatments for HD and to plan for future research studies of experimental drugs aimed at slowing or postponing the onset and progression of HD
Detailed Description: COHORT Cooperative Huntington Observational Research Trial is a coordinated research effort by Huntington Study Group research centers worldwide to prospectively collect data from consenting individuals who are affected by Huntingtons disease HD and who are part of an HD family The systematically accrued data from annual prospective assessments will relate clinical characteristics phenotypes between families with genetic and environmental factors The knowledge from these relationships will better inform us about the onset and progression of HD help identify potential interventions for HD and aid in planning research studies of experimental treatments aimed at slowing or postponing the onset of HD The consented collection of biological samples will further provide research material and correlative data for scientists to identify biomarkers that parallel the development and progression of HD Identification of biomarkers will in turn contribute to our understanding of HD and enhance the efficiency and power of disease-modifying therapeutic trials

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None